Abstract C162: Prespecified interim analysis of the DARolutamide ObservationaL (DAROL) study in Black/African American patients with nonmetastatic castration-resistant prostate cancer (nmCRPC)
Year: 2024
Type: conference-abstract
Authors: Evan Y. Yu, Christopher Pieczonka, Hiroyoshi Suzuki, Alberto Briganti, Murilo Luz, Declan Murphy, Patrick Adorjan, Mercedeh Ghadessi, Frank Verholen, Andrew J. Armstrong
Institutions: University of Washington, Fred Hutch Cancer Center, Toho University, Toho University Medical Center Sakura Hospital, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Hospital Erasto Gaertner, The University of Melbourne, Peter MacCallum Cancer Centre, Bayer (Switzerland), Bayer (United States), Duke University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4402708963